Friday 6 November 2026 Export VCYT’s income statement to Excel — free account

Veracyte, Inc.

VCYT Healthcare Diagnostics & Research

Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.

Revenue: +15.1%
EPS: +62.5%
Free cash flow: −9.63%

Quarter to September 2026, against a year earlier

24.11 28.41 −54.09%

Follow VCYT

Alert me

Market cap: $1.9B
P/E: 15.2×
Fwd P/E: 45.2×
Dividend yield: —
F-score: 8/9
Altman Z: 21.08
Beneish M: −2.66
Dividend safety: n/a

Overview

Veracyte, Inc. (VCYT) Book value per share

Alert me on Book value per share

Veracyte, Inc.'s book value per share at the end of fiscal 2025 was 16.7×, up 8.39% from 15.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 17.8×. Over the past ten years it has ranged from 1.1× (fiscal 2017) to 16.7× (fiscal 2025) — the current reading is the highest in ten years. Veracyte, Inc. ranks 16th of 49 Diagnostics & Research companies by book value per share.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VCYT/book-value-per-share" width="100%" height="360" style="border:0" loading="lazy" title="Veracyte, Inc. book value per share, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VCYT/metrics/book-value-per-share">Veracyte, Inc. (VCYT) book value per share — stockrow.com</a></p>

Period	Book value per share	Change
FY2025	16.7×	8.39%
FY2024	15.4×	6.97%
FY2023	14.4×	(4.36%)
FY2022	15.0×	(6.96%)
FY2021	16.2×	104.13%
FY2020	7.9×	52.45%
FY2019	5.2×	140.90%
FY2018	2.2×	96.35%
FY2017	1.1×	(46.91%)
FY2016	2.1×	4.81%

Period	Book value per share	Change
Sep 2026	17.8×	2.55%
Jun 2026	17.4×	2.71%
Mar 2026	16.9×	1.43%
Dec 2025	16.7×	4.31%
43 more quarters	Free account

Against its own ten years

Low 1.1× High 16.7×

Ten-year median 7.9×

Current reading's percentile 100

Company	Book value per share
GRAL GRAIL, Inc. compare	52.5×
RDNT RadNet, Inc. compare	17.9×
VCYT Veracyte, Inc.	17.8×
CDNA CareDx, Inc. compare	9.0×
WGS GeneDx Holdings Corp. compare	8.2×
NEO NeoGenomics, Inc. compare	6.2×
SHC Sotera Health Company compare	2.6×
ADPT Adaptive Biotechnologies Corporation compare	1.1×
BLLN BillionToOne, Inc. compare	0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

Veracyte, Inc. (VCYT) Book value per share

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on VCYT

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on VCYT

Stockrow Weekly